000 | 01808cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030700.0 | ||
008 | 121002s2012 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.11.33.Ph.D.2012.Sh.A | ||
100 | 0 | _aShereen Abdelalem Mohamed Kabeal | |
245 | 1 | 0 |
_aAutologous mesenchymal stem cell transplantation in end stage liver disease / _cShereen Abdelalem Mohamed Kabeal ; Supervised Hosny Mohamed Salama , Omar Sayed Alfi , Eman Medhat Hassan |
246 | 1 | 5 | _aزراعة الخلايا الحشوية الذاتية في مرضي التليف الكبدى |
260 |
_aCairo : _bShereen Abdelalem Mohamed Kabeal , _c2012 |
||
300 |
_a187 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine | ||
520 | _aHepatic cirrhosis is the end-stage of chronic liver diseases. Liver transplantation has been the most effective treatment for these patients but is critically limited by the shortage of available donor. The transplantation of autologous bone marrow-derived stem cells holds great potential for treating hepatic cirrhosis. Twenty patients with end stage liver disease that underwent autologous mesenchymal stem cells transplantation when infused into the peripheral vein | ||
530 | _aIssued also as CD | ||
653 | 4 | _aAutologous | |
653 | 4 | _aEnd stage liver disease | |
653 | 4 | _aMesenchymal stem cells | |
700 | 0 |
_aEman Medhat Hassan , _eSupervisor |
|
700 | 0 |
_aHosny Mohamed Salama , _eSupervisor |
|
700 | 0 |
_aOmar Sayed Alfi , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c39741 _d39741 |